BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20810538)

  • 1. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.
    Gallagher CJ; Balliet RM; Sun D; Chen G; Lazarus P
    Drug Metab Dispos; 2010 Dec; 38(12):2204-9. PubMed ID: 20810538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics.
    Sun D; Chen G; Dellinger RW; Sharma AK; Lazarus P
    Pharmacogenet Genomics; 2010 Oct; 20(10):575-85. PubMed ID: 20697310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.
    Chen G; Giambrone NE; Lazarus P
    Pharmacogenet Genomics; 2012 Mar; 22(3):183-90. PubMed ID: 22228205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
    Balliet RM; Chen G; Gallagher CJ; Dellinger RW; Sun D; Lazarus P
    Cancer Res; 2009 Apr; 69(7):2981-9. PubMed ID: 19318555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
    Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
    Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacogenetic study of vorinostat glucuronidation.
    Kang SP; Ramirez J; House L; Zhang W; Mirkov S; Liu W; Haverfield E; Ratain MJ
    Pharmacogenet Genomics; 2010 Oct; 20(10):638-41. PubMed ID: 20729791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.
    Bauman JN; Goosen TC; Tugnait M; Peterkin V; Hurst SI; Menning LC; Milad M; Court MH; Williams JA
    Drug Metab Dispos; 2005 Sep; 33(9):1349-54. PubMed ID: 15980101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.
    Chen G; Giambrone NE; Dluzen DF; Muscat JE; Berg A; Gallagher CJ; Lazarus P
    Cancer Res; 2010 Oct; 70(19):7543-52. PubMed ID: 20876810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver.
    Sharma S; Ahire D; Basit A; Lajoie M; Wang C; Lee MS; Blithe DL; Amory JK; Singh DK; Heyward S; Prasad B
    Drug Metab Dispos; 2022 Dec; 50(12):1493-1500. PubMed ID: 36184078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
    Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
    Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.
    Zhang H; Basit A; Busch D; Yabut K; Bhatt DK; Drozdzik M; Ostrowski M; Li A; Collins C; Oswald S; Prasad B
    Biochem Pharmacol; 2018 Oct; 156():32-42. PubMed ID: 30086285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
    Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
    Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.
    Sten T; Finel M; Ask B; Rane A; Ekström L
    Steroids; 2009 Nov; 74(12):971-7. PubMed ID: 19643121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
    Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
    Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.
    Eskandari-Nasab E; Hashemi M; Rezaei H; Fazaeli A; Mashhadi MA; Moghaddam SS; Arbabi F; Jahantigh M; Taheri M
    Mol Biol Rep; 2012 Dec; 39(12):10531-9. PubMed ID: 23053953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.
    Hirata H; Hinoda Y; Zaman MS; Chen Y; Ueno K; Majid S; Tripsas C; Rubin M; Chen LM; Dahiya R
    Carcinogenesis; 2010 Sep; 31(9):1620-6. PubMed ID: 20554747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.
    Karypidis AH; Olsson M; Andersson SO; Rane A; Ekström L
    Pharmacogenomics J; 2008 Apr; 8(2):147-51. PubMed ID: 17387331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.